Usefulness of a Visual Analogue Scale to Evaluate Anxiety in the Painful Hospitalized Patient
EVANX
2 other identifiers
observational
406
1 country
4
Brief Summary
Today, there is no simple tool for measuring patient anxiety. The primary purpose of this study is to evaluate the ability of the Visual Analogue Scale (VAS) to measure anxiety in painful hospitalized patients, and to correlate it to STAI-Ya and HAD-7A auto questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2017
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 19, 2017
CompletedFirst Posted
Study publicly available on registry
June 21, 2017
CompletedStudy Start
First participant enrolled
August 7, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedMarch 22, 2019
March 1, 2019
10 months
June 19, 2017
March 21, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation between Anxiety VAS and STAI-Ya and HAD-7A scores
Correlation between Anxiety-VAS and STAI-Ya, HAD-7A scores.
at inclusion
Secondary Outcomes (3)
Number of patients presenting anxiety.
at inclusion
Link between anxiety scores and several factors
at inclusion
Concordance between STAI-Ya and HAD-7A scales.
at inclusion
Study Arms (1)
Painful hospitalized patient
The anxiety of those patients will be measured with an Anxiety VAS
Interventions
Anxiety will be measure with a 10-points visual analogic scale (VAS)
Eligibility Criteria
Painful hospitalized patient
You may qualify if:
- Aged ≥ 18 years old
- Patient hospitalized in a medical or chirurgical service.
- Patient presenting a moderate to acute pain (Pain VAS ≥4)
You may not qualify if:
- Patient unable to fill in the auto questionnaire
- Refusal, unwillingness of the patient to participate to the study
- Patients under guardianship, trusteeship and judicial protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lille Catholic Universitylead
- Centre Hospitalier de Roubaixcollaborator
- Tourcoing Hospitalcollaborator
- Wattrelos hospitalcollaborator
Study Sites (4)
Lille Catholic Hospitals
Lille, Nord, 59462, France
Roubaix Hospital
Roubaix, 59100, France
Tourcoing hospital
Tourcoing, 59200, France
Wattrelos hospital
Wattrelos, 59150, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vincent Ducoulombier, MD
Lille Catholic University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 19, 2017
First Posted
June 21, 2017
Study Start
August 7, 2017
Primary Completion
June 1, 2018
Study Completion
September 1, 2018
Last Updated
March 22, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share